Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Women with polycystic ovary syndrome have a higher risk of certain fractures.